MedTrace Logo

Influence of Losartan and Diphenhydramine on Emotional and Cognitive Functions in Healthy Human Subjects

NCT01321021 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-05-03

No results posted yet for this study

Summary

This project aims at identifying novel pharmacological targets for the treatment of memory disorders.

Conditions

  • Memory, Long-Term
  • Memory, Short-Term

Interventions

DRUG

Losartan, Diphenhydramine, Placebo

placebo controlled crossover study with two arms: Losartan 40mg, Diphenhydramine 40mg

Sponsors & Collaborators

  • Clinical Trial Unit, University Hospital Basel, Switzerland

    collaborator OTHER

  • Prof. Dominique de Quervain, MD

    lead OTHER

Principal Investigators

  • Dominique de Quervain, Prof. MD · University of Basel, Faculty of Psychology and Medecine, Division of Cognitive Neuroscience

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-07-31
Completion
2011-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321021 on ClinicalTrials.gov